---
schema_version: "secwatch.filing_event.v1"
accession: "0001606498-23-000011"
form_type: "8-K"
ticker: "AVNS"
cik: "0001606498"
company_name: "AVANOS MEDICAL, INC."
filed_at: "2023-01-11T23:59:59+00:00"
generated_at: "2026-06-20T16:33:16.865308+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Avanos launches 3-year transformation; CFO Greiner adds Chief Transformation Officer role; SVP Haydon to depart

## Summary
- Three-year plan: combine Chronic Care & Pain franchises, exit low-margin products, cost management, and focused M&A.
- CFO Michael Greiner assumes additional role of Chief Transformation Officer to lead the transformation.
- Kerr Holbrook appointed SVP & Chief Commercial Officer, overseeing combined commercial organization.
- William D. Haydon, SVP & GM Pain Franchise, to depart March 31, 2023; receives $972K severance plus up to $300K transition bonus.
- Company currently unable to estimate total transformation costs; will file amended 8-K within four business days.

## SEC filing metadata
- accession: 0001606498-23-000011
- form_type: 8-K
- ticker: AVNS
- cik: 0001606498
- company_name: AVANOS MEDICAL, INC.
- filed_at: 2023-01-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.05, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/avns-20230110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606498-23-000011
- JSON: https://secwatch.observer/filing/0001606498-23-000011.json
- Plain text: https://secwatch.observer/filing/0001606498-23-000011.txt

## Key facts
- Executive change
  William D. Haydon was terminated as Senior Vice President and General Manager, Pain Franchise at AVANOS MEDICAL, INC..
  - Action: terminated
  - Role: Senior Vice President and General Manager, Pain Franchise
  source text: On January 10, 2023, the Company and William D. Haydon, the Company’s Senior Vice President and General Manager, Pain Franchise, entered into a Severance and Separation Agreement (the “Severance and Separation Agreement”) pursuant to which: (i) Mr. Haydon’s employment with the Company will terminate effective March 31, 2023 (the “Separation Date”);
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm
- Restructurings & Charges
  AVANOS MEDICAL, INC. announced a restructuring affecting Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories.
  - Type: restructuring
  - Affected area: Chronic Care and Pain franchises combined into single commercial organization; exit certain low-margin, low-growth product categories
  source text: On January 10, 2023, Avanos Medical, Inc. (the “Company”) approved a three-year transformation process (the “Transformation Process”) pursuant to which the Company plans to: (i) combine its Chronic Care and Pain franchises into a single commercial organization focused on the Digestive Health and Orthopedic Pain & Recovery product categories; (ii) exit certain low-margin, low-growth product categories, including through targeted divestitures; (iii) undertake additional cost management activities to enhance the Company’s operating profitability; and (iv) pursue efficient capital allocation strategies, including through acquisitions that meet the Company’s strategic and financial criteria.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1606498/000160649823000011/0001606498-23-000011-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.